Insider Trading activities of Chemocentryx, Inc. insiders. , Part 3

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Chemocentryx, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Chemocentryx, Inc. since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Chemocentryx, Inc. since 2005. The reporting company's ticker symbol is CCXI. The reporting company's CIK number is 1340652.
The total value of stock buying since 2005 is $19,095,018.
The total value of stock sales since 2005 is $26,499,051.
The total value of stock option exercises since 2005 is $3,182,228.


 1   2   3 

Table 2. Detailed insider stock purchases, sales, and option exercises of Chemocentryx, Inc. insiders (CCXI) , Part 3
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2013-01-31 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 3,280 11.51 37,756
2013-01-31 Jaen Juan C. (SVP, Drug Discovery & CSO) Option Ex 3,280 4.30 14,104
2013-01-29 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 4,892 11.45 56,013
2013-01-29 Jaen Juan C. (SVP, Drug Discovery & CSO) Option Ex 4,892 4.30 21,035
2013-01-28 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 2,710 11.40 30,894
2013-01-28 Jaen Juan C. (SVP, Drug Discovery & CSO) Option Ex 2,710 4.30 11,653
2013-01-25 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 96 11.35 1,089
2013-01-25 Jaen Juan C. (SVP, Drug Discovery & CSO) Option Ex 96 4.30 412
2013-01-24 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 1,200 11.35 13,622
2013-01-24 Jaen Juan C. (SVP, Drug Discovery & CSO) Option Ex 1,200 4.30 5,160
2013-01-22 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 100 11.35 1,135
2013-01-22 Jaen Juan C. (SVP, Drug Discovery & CSO) Option Ex 100 4.30 430
2013-01-18 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 2,759 11.16 30,798
2013-01-18 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 2,759 .60 1,655
2013-01-17 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 1,300 11.15 14,498
2013-01-17 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 1,300 2.45 3,185
2013-01-16 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 600 11.18 6,705
2013-01-16 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 600 4.30 2,580
2013-01-15 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 800 11.15 8,920
2013-01-15 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 800 4.30 3,440
2013-01-12 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 3,305 11.35 37,511
2013-01-12 Jaen Juan C. (SVP, Drug Discovery & CSO) Option Ex 3,305 4.30 14,211
2013-01-08 Lucas Roger C (Director) Sale 2,099 11.00 23,097
2013-01-07 Lucas Roger C (Director) Sale 1,800 11.16 20,095
2013-01-04 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 96 11.35 1,089
2013-01-04 Jaen Juan C. (SVP, Drug Discovery & CSO) Option Ex 96 4.30 412
2013-01-04 Lucas Roger C (Director) Sale 700 11.08 7,758
2013-01-03 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 100 11.35 1,135
2013-01-03 Jaen Juan C. (SVP, Drug Discovery & CSO) Option Ex 100 4.30 430
2013-01-03 Lucas Roger C (Director) Sale 401 11.10 4,452
2013-01-02 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 5,821 11.30 65,777
2013-01-02 Jaen Juan C. (SVP, Drug Discovery & CSO) Option Ex 5,821 4.30 25,030
2012-12-18 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 7,500 11.10 83,250
2012-12-18 Jaen Juan C. (SVP, Drug Discovery & CSO) Option Ex 7,500 4.30 32,250
2012-12-18 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 4,843 10.94 52,982
2012-12-18 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 4,843 2.45 11,865
2012-12-17 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 7,500 11.00 82,500
2012-12-17 Jaen Juan C. (SVP, Drug Discovery & CSO) Option Ex 7,500 4.30 32,250
2012-12-04 Kanaya Susan M (SVP, Finance, CFO and Sec.) Sale 4,693 11.98 56,217
2012-12-04 Kanaya Susan M (SVP, Finance, CFO and Sec.) Option Ex 4,693 2.00 9,386
2012-12-04 Lucas Roger C (Director) Sale 4,800 11.97 57,441
2012-12-03 Kanaya Susan M (SVP, Finance, CFO and Sec.) Sale 404 11.93 4,817
2012-12-03 Kanaya Susan M (SVP, Finance, CFO and Sec.) Option Ex 404 2.00 808
2012-12-03 Lucas Roger C (Director) Sale 200 11.72 2,344
2012-11-30 Kanaya Susan M (SVP, Finance, CFO and Sec.) Sale 830 11.94 9,910
2012-11-30 Kanaya Susan M (SVP, Finance, CFO and Sec.) Option Ex 830 2.00 1,660
2012-11-29 Kanaya Susan M (SVP, Finance, CFO and Sec.) Sale 3,839 11.89 45,661
2012-11-29 Kanaya Susan M (SVP, Finance, CFO and Sec.) Option Ex 3,839 2.00 7,678
2012-11-28 Kanaya Susan M (SVP, Finance, CFO and Sec.) Sale 234 11.90 2,784
2012-11-28 Kanaya Susan M (SVP, Finance, CFO and Sec.) Option Ex 234 2.00 468
2012-11-26 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 201 12.10 2,432
2012-11-26 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 201 .60 120
2012-11-23 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 795 12.02 9,556
2012-11-23 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 795 2.45 1,947
2012-11-21 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 1,393 11.90 16,578
2012-11-21 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 1,393 4.30 5,989
2012-11-20 Schall Thomas J. (President and CEO) Sale 999 12.01 11,996
2012-11-20 Bekker Petrus (SVP of Medical & Clinical) Sale 3,439 12.01 41,312
2012-11-20 Bekker Petrus (SVP of Medical & Clinical) Option Ex 3,439 .60 2,063
2012-11-20 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 3 12.10 36
2012-11-20 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 3 .60 1
2012-11-19 Schall Thomas J. (President and CEO) Sale 1,101 12.02 13,231
2012-11-19 Bekker Petrus (SVP of Medical & Clinical) Sale 1,561 12.01 18,749
2012-11-19 Bekker Petrus (SVP of Medical & Clinical) Option Ex 1,561 .60 936
2012-11-19 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 7 12.10 84
2012-11-19 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 7 .60 4
2012-11-16 Schall Thomas J. (President and CEO) Sale 2,000 12.00 24,000
2012-11-16 Bekker Petrus (SVP of Medical & Clinical) Sale 10,000 11.90 119,000
2012-11-15 Schall Thomas J. (President and CEO) Sale 3,400 12.18 41,422
2012-11-14 Schall Thomas J. (President and CEO) Sale 15,000 12.75 191,250
2012-11-14 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 2,000 12.95 25,900
2012-11-06 Schall Thomas J. (President and CEO) Sale 22,500 12.01 270,112
2012-11-06 Bekker Petrus (SVP of Medical & Clinical) Sale 9,300 12.01 111,702
2012-11-06 Bekker Petrus (SVP of Medical & Clinical) Option Ex 9,300 .60 5,580
2012-11-06 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 5,833 12.01 70,030
2012-11-06 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 3,676 12.10 44,479
2012-11-06 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 3,676 .60 2,205
2012-11-06 Lampert Mark N (10% Owner) Buy 40,000 12.00 479,840
2012-11-06 Kanaya Susan M (SVP, Finance, CFO and Sec.) Sale 16,029 11.92 191,017
2012-11-06 Kanaya Susan M (SVP, Finance, CFO and Sec.) Option Ex 16,029 2.00 32,058
2012-11-06 Lucas Roger C (Director) Sale 2,500 11.83 29,572
2012-11-05 Lucas Roger C (Director) Sale 2,500 11.34 28,357
2012-10-22 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 316 10.70 3,379
2012-10-22 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 316 .60 189
2012-10-19 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 2,900 11.01 31,914
2012-10-19 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 2,900 .60 1,740
2012-10-18 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 7,702 10.83 83,412
2012-10-18 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 7,702 2.45 18,869
2012-10-04 Lucas Roger C (Director) Sale 1,893 11.47 21,710
2012-10-03 Lucas Roger C (Director) Sale 3,107 11.38 35,373
2012-10-01 Schall Thomas J. (President and CEO) Sale 15,000 11.53 172,950
2012-10-01 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 2,100 11.98 25,158
2012-10-01 Kanaya Susan M (SVP, Finance, CFO and Sec.) Sale 3,971 11.89 47,215
2012-10-01 Kanaya Susan M (SVP, Finance, CFO and Sec.) Option Ex 3,971 2.00 7,942
2012-09-27 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 300 11.95 3,585
2012-09-25 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 7,401 11.96 88,478
2012-09-25 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 5,459 11.86 64,727
2012-09-25 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 5,459 2.45 13,374
2012-09-24 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 2,705 11.96 32,357
2012-09-21 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 200 12.01 2,401
2012-09-20 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 661 12.01 7,937
2012-09-18 Lucas Roger C (Director) Sale 1,200 11.71 14,054
2012-09-17 Bekker Petrus (SVP of Medical & Clinical) Sale 400 12.12 4,849
2012-09-17 Bekker Petrus (SVP of Medical & Clinical) Option Ex 400 .60 240
2012-09-17 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 800 12.05 9,637
2012-09-17 Lucas Roger C (Director) Sale 3,800 11.92 45,284
2012-02-13 Techne Corp /mn/ (10% Owner) Buy 500,000 10.00 5,000,000
2012-02-10 Parker Geoffrey M. (Director) Buy 4,600 10.97 50,462
 1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of CCXI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Chemocentryx, Inc. (symbol CCXI, CIK number 1340652) see the Securities and Exchange Commission (SEC) website.